Published in Acta Derm Venereol on November 01, 1994
Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol (1968) 16.77
Mast cells. Physiol Rev (1997) 6.51
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (1988) 6.18
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol (1981) 3.96
Competition between, and effectiveness of, IgG and IgM antibodies in indirect fluorescent antibody and other tests. J Immunol (1967) 3.72
Natural and immune human antibodies reactive with antigens of virulent Neisseria gonorrhoeae: immunoglobulins G, M, And A. J Bacteriol (1967) 3.56
Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A (1985) 3.31
Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet (2001) 3.26
T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet (1986) 3.20
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science (1966) 3.00
Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science (1983) 2.96
Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest (1984) 2.66
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature (1981) 2.44
Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43
Peptide therapy for diabetes in NOD mice. Lancet (1994) 2.28
Davener's dermatosis: a variant of friction hypermelanosis. J Am Acad Dermatol (2000) 2.26
Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1990) 2.23
Serum antibody response in experimental human gonorrhoea. Immunoglobulins G, A, and M. Br J Vener Dis (1969) 2.17
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science (1988) 2.16
T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum (1985) 2.06
T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol (1983) 2.05
Antibiodies of the IgG, IgM, and IgA classes in newborn and adult sera reactive with gram-negative bacteria. J Clin Invest (1968) 1.98
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.97
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J (1994) 1.87
Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol (1982) 1.84
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Immune information, self-organization and meaning. Int Immunol (1998) 1.73
Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology (2012) 1.67
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. J Am Acad Dermatol (1998) 1.64
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum (1990) 1.60
Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone. Science (1972) 1.58
T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol (1983) 1.58
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science (1989) 1.56
Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med (1996) 1.47
Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci (1999) 1.44
Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science (1982) 1.44
Effector T lymphocyte line cells migrate to the thymus and persist there. Nature (1982) 1.44
Transformation of thymocytes by thymus epithelium derived from AKR mice. Nature (1976) 1.43
Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nat Med (1998) 1.43
Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature (1984) 1.42
Regulation of autoimmune disease physiological and therapeutic. Immunol Rev (1986) 1.41
Flow cytometric DNA analysis of classic and steroid-induced Kaposi's sarcoma. Br J Dermatol (1995) 1.37
Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction. J Exp Med (1970) 1.37
Autosensitization in vitro. J Exp Med (1971) 1.33
Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun (2000) 1.32
Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci U S A (1987) 1.31
Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol (2000) 1.30
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
T lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis or arthritis. Eur J Immunol (1984) 1.25
Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. J Immunol (1982) 1.24
Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes (1997) 1.24
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol (1990) 1.22
Cell-free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts. Eur J Immunol (1976) 1.22
Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. J Immunol (1994) 1.21
Regulation of autosensitization. The immune activation and specific inhibition of self-recognizing thymus-derived lymphocytes. J Exp Med (1973) 1.20
Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol (1987) 1.19
A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A (1996) 1.19
T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis. Transplant Rev (1972) 1.19
Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol (2001) 1.19
Induction of T-cells differentiation in vitro by thymus epithelial cells. Ann N Y Acad Sci (1975) 1.17
Rejection of tumor allografts by mouse spleen cells sensitized in vitro. J Exp Med (1971) 1.14
Thymus reticulum cell cultures confer T cell properties on spleen cells from thymus-deprived animals. Eur J Immunol (1973) 1.14
T lymphocytes with promiscuous cytotoxicity. Nature (1976) 1.13
Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen. Nature (1977) 1.13
Synaptotagmin II negatively regulates Ca2+-triggered exocytosis of lysosomes in mast cells. J Exp Med (1999) 1.13
Autosensitization of lymphocytes against thymus reticulum cells. Science (1972) 1.13
Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol (1974) 1.13
Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol (1985) 1.13
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial. Diabetes Metab Res Rev (2007) 1.11
The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect. Cell Immunol (1970) 1.10
Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet (2000) 1.10
Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes (1994) 1.10
Vaccination against autoimmune encephalomyelitis (EAE): attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line. Eur J Immunol (1981) 1.09
A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr Top Microbiol Immunol (1989) 1.09
Antigen-chip technology for accessing global information about the state of the body. Lupus (2006) 1.09
Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J (1999) 1.08
Autoimmune encephalomyelitis: activation of thymus lymphocytes against syngeneic brain antigens in vitro. Science (1974) 1.08
NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun (1996) 1.07
Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin Exp Immunol (2008) 1.06
Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J Autoimmun (1999) 1.05
T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J Clin Invest (1992) 1.05
Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur J Immunol (2001) 1.04
Lymphocyte receptors for autoantigens, autologous serum inhibits self-recognition. Nat New Biol (1973) 1.04
Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein. J Immunol (1986) 1.04
Autoimmunity can benefit self-maintenance. Immunol Today (2000) 1.04
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. J Clin Invest (1989) 1.03
Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific. J Immunol (1983) 1.02
T-cell vaccination. Immunol Today (1988) 1.02
In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. Int J Cancer (1973) 1.01
Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. Int Immunol (1997) 1.01
Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells. J Exp Med (1985) 1.01